ELF4 and central nervous system cancer: The independent capacity of ELF4 to evaluate glioma outcomes was assessed through multivariate Cox regression analysis in CGGA (HR: 1.21, 95%CI: 1.09-1.34, p<0.001), TCGA (HR: 1.19, 95%CI: 1.01-1.41, p=0.043), and Gravendeel (HR: 1.44, 95%CI: 1.15-1.80, p=0.002) datasets, as presented in Fig. 2G-H and Fig. S2.